SR Guntupalli, D Spinosa, S Wethington, R Eskander… - bmj, 2023 - bmj.com
Venous thromboembolism (VTE) is a major cause of both morbidity and mortality in patients with cancer. Venous thromboembolism, which includes both deep vein thrombosis and …
DA Tsakiris, E Gavriilaki, I Chanou… - Bone marrow …, 2024 - nature.com
Hematopoietic stem cell transplantation (HCT) represents a curative treatment option for certain malignant and nonmalignant hematological diseases. Conditioning regimens before …
I Deguchi, S Takahashi - Journal of Atherosclerosis and Thrombosis, 2023 - jstage.jst.go.jp
Intracranial branch atheromatous disease (BAD) is a pathological condition characterized by the occlusion of a relatively large perforating branch (700–800 µm) near the orifice of a …
V Kumar, L Ilkhanoff - Frontiers in Cardiovascular Medicine, 2024 - frontiersin.org
Anticoagulation is the mainstay of stroke prevention in appropriate patients with atrial fibrillation. Due to advances in pharmacotherapy the anticoagulants used for this purpose …
P Garot, MW Bergmann - Journal of Clinical Medicine, 2023 - mdpi.com
The most common arrhythmia, atrial fibrillation (AF), increases with age and is associated with a 5-fold increased risk of stroke. Although lifelong oral anticoagulation (OAC) is strongly …
F Inchingolo, AM Inchingolo, F Piras, L Ferrante… - …, 2024 - pmc.ncbi.nlm.nih.gov
Background: Anticoagulant drugs are a valuable tool for minimizing thrombotic risks in at- risk patients. The purpose of this study is to conduct a literature review highlighting the …
P Pazhani, S Arumugam, JP Dharmian… - Journal of Dispersion …, 2024 - Taylor & Francis
Venous thromboembolism (VTE) is a potentially fatal vascular disease that can be successfully managed to reduce the risk of mortality and impairment. Anticoagulation …
J Friebel, M Wegner, L Blöbaum, PA Schencke… - International Journal of …, 2024 - mdpi.com
Patients with first-diagnosed atrial fibrillation (FDAF) exhibit major adverse cardiovascular events (MACEs) during follow-up. Preclinical models have demonstrated that thrombo …
Y Zeng, G Cen, G Zhou, X Zhu, L Huang, X Wang - Molecules, 2024 - mdpi.com
A new process route suitable for the industrial production of BAY2433334 has been developed in this paper, which avoids the patent limitations of the originator company of …